Skip to main content

AVAI BIO, INC.

corporate_fare Company Profile

AVAI BIO, INC.

AVAI·OTC·Technology·CIK 0001740797

Avant Technologies Inc. is a technology company that specializes in acquiring, creating, and developing advanced technologies using artificial intelligence (AI), and also provides information technology consulting services. The company considers itself an expert in AI-based information technology. Key acquisitions include Avant! AI and a Joint Venture and License Agreement with Ainnova Tech Inc. These acquisitions provide resources in full-stack software development, database management, data integration, project management, and cloud services. Avant aims to provide innovative and effective AI solutions that transform businesses and positively impact society, pushing the boundaries of AI technology to empower organizations. The company's technology is designed as a self-sustained system that prepares data from unlabeled information using Unsupervised Clustering, then analyzes it with various proprietary supervised learning techniques to improve data efficiency. Unsupervised learning pre-processes and extracts meaningful features from raw or unlabeled data, preparing them as inputs for the supervised learning model, which facilitates True Learning from Experience. This technique learns relevant information from many source domains, evaluates it, and applies it to related or different domains where information may be scarce, representing a true learning capability. Avant leverages knowledge from source domains to improve performance in other domains and for factual discovery/conclusion by learning data. Avant's Unsupervised learning techniques, such as clustering, identify groups or patterns in data to reach conclusions. Its supervised learning mechanism then creates new datasets (information) for further domains, improving classification and regression tasks, which is described as a true reasoning mechanism. On May 23, 2023, the company filed an application with FINRA to change its name and trading symbol.

AVAI BIO, INC. (OTC:AVAI) is a publicly traded company in the Technology sector. Wiseek monitors AVAI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • AVAI BIO Terminates AI Healthcare Joint Venture with Ainnova Tech
  • AVAI BIO Reports Substantial Doubt About Going Concern, Ineffective Controls, and Worsening Financials

Financial Snapshot

Fiscal year ended March 31, 2025
Net Income
-$1.14M
Op. Cash Flow
-$1.16M
Operating Income
-$1.14M
Cash & Equivalents
$81.05K
Debt / Equity
0.00×
Shares Outstanding
137.36M sh
Source: 10-K · filed 2025-07-08 · accession 0001740797-25-000038
Browse all tickers starting with A →
$0.15
52-week range · as of 2026-05-08 $0.25 – $0.8277
Market cap
$20.74M
Volume
75.3K (0.4× avg)
3-mo avg 188.8K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AVAI - Latest Insights

AVAI
May 08, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.300
Real-time Price: $0.150 info
Change: -$0.150 (-50%) info
Market Cap: $20.738M info
AVAI
Feb 12, 2026, 4:20 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4021
Real-time Price: $0.150 info
Change: -$0.2521 (-63%) info
Market Cap: $20.738M info